These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 21685544

  • 1. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
    Scherrenburg J, Schellens IM, van Baarle D.
    Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ.
    J Infect Dis; 2001 Aug 01; 184(3):256-67. PubMed ID: 11443550
    [Abstract] [Full Text] [Related]

  • 4. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Natta MV, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA, Studies of Ocular Complications of AIDS Research Group.
    J Infect Dis; 2006 Dec 01; 194(11):1537-46. PubMed ID: 17083038
    [Abstract] [Full Text] [Related]

  • 5. Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants.
    Gibson L, Dooley S, Trzmielina S, Somasundaran M, Fisher D, Revello MG, Luzuriaga K.
    J Infect Dis; 2007 Jun 15; 195(12):1789-98. PubMed ID: 17492595
    [Abstract] [Full Text] [Related]

  • 6. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
    Komanduri KV, Donahoe SM, Moretto WJ, Schmidt DK, Gillespie G, Ogg GS, Roederer M, Nixon DF, McCune JM.
    Virology; 2001 Jan 20; 279(2):459-70. PubMed ID: 11162802
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
    Jansen CA, Piriou E, De Cuyper IM, van Dort K, Lange JM, Miedema F, van Baarle D.
    Antivir Ther; 2006 Jan 20; 11(1):105-16. PubMed ID: 16518966
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, Reiss P, Bakker M, Miedema F, Tesselaar K, van Baarle D.
    J Infect Dis; 2005 Mar 15; 191(6):873-80. PubMed ID: 15717261
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA, Van Gulck E, Ponsaerts P, Nijs G, Lenjou M, Apers L, Kint I, Heyndrickx L, Vanham G, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF.
    J Immunother; 2006 Mar 15; 29(5):512-23. PubMed ID: 16971807
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs.
    Gyulai Z, Endresz V, Burian K, Pincus S, Toldy J, Cox WI, Meric C, Plotkin S, Gönczöl E, Berencsi K.
    J Infect Dis; 2000 May 15; 181(5):1537-46. PubMed ID: 10823751
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rapid generation of CMV pp65-specific T cells for immunotherapy.
    Bao L, Sun Q, Lucas KG.
    J Immunother; 2007 May 15; 30(5):557-61. PubMed ID: 17589296
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
    Jacobson MA, Sinclair E, Bredt B, Agrillo L, Black D, Epling CL, Carvidi A, Ho T, Bains R, Adler SP.
    J Clin Virol; 2006 Mar 15; 35(3):332-7. PubMed ID: 16387547
    [Abstract] [Full Text] [Related]

  • 17. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P.
    Transpl Immunol; 2009 Mar 15; 20(4):238-42. PubMed ID: 19032982
    [Abstract] [Full Text] [Related]

  • 18. Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease.
    Stone SF, Price P, French MA.
    J Antimicrob Chemother; 2006 Apr 15; 57(4):585-8. PubMed ID: 16504998
    [Abstract] [Full Text] [Related]

  • 19. Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection.
    Gallez-Hawkins G, Thao L, Lacey SF, Martinez J, Li X, Franck AE, Lomeli NA, Longmate J, Diamond DJ, Spielberger R, Forman SJ, Zaia JA.
    Biol Blood Marrow Transplant; 2005 Nov 15; 11(11):890-902. PubMed ID: 16275592
    [Abstract] [Full Text] [Related]

  • 20. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D, Fornara C, Chiesa A, Caldera D, Alessandrino EP, Gerna G.
    Haematologica; 2008 Feb 15; 93(2):248-56. PubMed ID: 18245650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.